Market Tracker

08/29 6:01pm ET

Dyax Corp (NASDAQ:DYAX)

10.21
Data as of Aug 29
 +0.19 / +1.90%
Today’s Change
4.20
Today|||52-Week Range
10.99
+35.50%
Year-to-Date

Today’s Trading

Previous close10.02
Today’s open10.05
Day’s range9.91 - 10.22
Volume606,086
Average volume (3 months)1,074,789
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)+13.33%
Earnings growth (this year)+28.02%
Earnings growth (next 5 years)+18.64%
Revenue growth (last year)-1.32%
P/E ratioNM
Price/Sales15.17
Price/Book47.21

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...+0.06+0.97%
KERXKeryx Biopharmaceuti...+0.38+2.13%
ABCOAdvisory Board Co+0.82+1.68%
SGMOSangamo BioSciences ...+0.25+1.78%
Data as of 3:59pm ET, 08/29/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$53.9M
Annual profit (last year)-$27.8M
Net profit margin-51.51%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gustav A. Christensen
Chief Financial Officer &
Executive Vice President
George V. Migausky
Corporate headquarters
Burlington, Massachusetts

Forecasts